Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
34.47 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -298.408 | -214.529 | -163.918 | -107.641 | -73.812 | -50.422 | -27.115 | -9.157 | -6.019 |
| Depreciation & Amortization
| 2.785 | 1.098 | 0.983 | 0.922 | 0.948 | 0.887 | 0.471 | 0.128 | 0.092 |
| Deferred Income Tax
| 0 | -28.485 | 0 | 0.422 | -0.227 | -1.229 | 0 | 0 | 0 |
| Stock Based Compensation
| 69.386 | 40.937 | 28.268 | 17.352 | 10.427 | 6.294 | 2.32 | 0.271 | 0.27 |
| Change In Working Capital
| 11.635 | 8.044 | 18.612 | 1.096 | 0.376 | -2.133 | 5.298 | -0.721 | 0.189 |
| Accounts Receivables
| 17.541 | 14.648 | 10.994 | 6.293 | 2.723 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -6.293 | -2.723 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 10.994 | 6.293 | 2.723 | 0.696 | 7.361 | 0.047 | 0.3 |
| Other Working Capital
| -5.906 | -6.604 | -3.376 | -5.197 | -2.347 | -2.829 | -2.063 | -0.768 | -0.111 |
| Other Non Cash Items
| -11.368 | 26.628 | 0.85 | -0.739 | 0.261 | 0.222 | -0.433 | 0.48 | 0.154 |
| Operating Cash Flow
| -225.97 | -166.307 | -115.205 | -88.588 | -62.027 | -46.381 | -19.459 | -9.479 | -5.468 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -3.844 | -4.688 | -1.656 | -0.436 | -0.186 | -0.492 | -1.059 | -0.304 | -0.19 |
| Acquisitions Net
| 0 | 195.725 | 0.034 | 0.422 | -0.227 | -1.229 | 0 | 0 | 0 |
| Purchases Of Investments
| -1,161.703 | -532.857 | -329.817 | -125.404 | -135.592 | -108.136 | -118.399 | 0 | 0 |
| Sales Maturities Of Investments
| 575.799 | 337.132 | 157.493 | 69.357 | 135.995 | 150.295 | 0 | 0 | 0 |
| Other Investing Activites
| 14.931 | -195.725 | -0.034 | -0.422 | 0.227 | 1.229 | -118.399 | 0 | 0 |
| Investing Cash Flow
| -574.817 | -200.413 | -173.98 | -56.483 | 0.217 | 41.667 | -119.458 | -0.304 | -0.19 |
| Financing Activities: | |||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.212 | -0.048 |
| Common Stock Issued
| 970.048 | 369.019 | 117.242 | 249.542 | 114.283 | 0 | 106.472 | 12.035 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -0.059 | 0 | 0 | -0.005 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 40.387 | 19.925 | 4.721 | 3.137 | 0.288 | 0.126 | 63.726 | 12.035 | -0.01 |
| Financing Cash Flow
| 1,010.435 | 388.944 | 121.963 | 252.679 | 114.571 | 0.067 | 170.198 | 11.823 | -0.053 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 209.648 | 22.224 | -167.222 | 107.608 | 52.761 | -4.647 | 31.281 | 2.04 | -5.711 |
| Cash At End Of Period
| 265.845 | 56.197 | 33.973 | 201.195 | 93.587 | 40.826 | 45.473 | 14.192 | 12.152 |